涉嫌事實
梁競偉係大略-KY公司之董事長兼總經理 ,於105年9月起,以多個人頭帳戶相對成交製造交易熱絡表象,操縱大略-KY公司股價,並將不實營收記載於大略-KY公司財報及公開資訊觀測站,使投資人蒙受損失,涉嫌違反證券交易法證券交易法第155條第1項,而涉犯同法第171條第1項第1款之罪嫌。LIANG,CHING-WEI is the chairman and general manager of Da Lue-KY, Since September 2016, LIANG used multiple corresponding transactions to create vibrant securities transactions of Pharmally.LIANG made The false revenue was recorded in Da Lue-KY's financial reports and disclosed on the Market Observation Post System from 2016 to 2019, causing investors to suffer losses. LIANG is suspected of violating Article 155, Paragraph 1 of the Securities and Exchange Act and suspected of violating Article 171, Paragraph 1, Subparagraph 1 of the Act.